Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Tuesday, September 29

12:40 PM - 12:45 PM ET

1117 - Improving Radiation Oncology Nursing Competence through a Structured, Needs-Based Education Initiative
Speaker: Gay, Kailey, MSN, OCN, RN - Moffitt Cancer Center, Tampa, FL
12:40 PM - 12:50 PM ET

238 - Targeting Recurrent Glioblastoma with Stereotactic Radiosurgery and Tumor Treating Fields Guided by 18F-FET-PET: Long-Term Results from a Prospective Phase 2 Trial (TTaRGeT)
Speaker: Harat, Maciej, MD, PhD - Franciszek Lukaszczyk Oncology Center, Bydgoszcz, Kujawsko-Pomorsk
12:40 PM - 12:50 PM ET

244 - Cure Estimation using Reconstructed Kaplan-Meier Analyses in Randomized Phase III Oncology Trials (CUREMA): A Meta-Epidemiological Study
Speaker: Chauhan, Kimi, MD, BS, MTM - Mayo Clinic College of Medicine and Science Rochester, Rochester, MN
12:40 PM - 12:50 PM ET

250 - The Role of Docetaxel in Addition to Salvage Radiation and Androgen Deprivation in Men with High-Risk Prostate Cancer Post-Prostatectomy: Results of NRG GU002
Speaker: Hurwitz, Mark, MD, FASTRO - New York Medical College/Westchester Medical Center Health, Valhalla, NY
12:40 PM - 12:50 PM ET

261 - Clinical and Genomic Landscape of Recurrence After Concurrent Chemoradiotherapy and Adjuvant Immunotherapy in Unresectable NSCLC
Speaker: Olabode, Kolade, MD, MPH - Moffitt Cancer Center, Tampa, FL
12:40 PM - 12:50 PM ET

267 - Inter-Individual Variability in Thoracic vs. Abdominal Breathing Patterns Limits Generic SGRT Tracking in DIBH: A Prospective Optical Motion Capture Study
Speaker: Yousuf, Mohamed, PhD - Thomas Jefferson University, Philadelphia, PA
12:40 PM - 12:50 PM ET

274 - Osimertinib Combined with Stereotactic Body Radiotherapy vs. Osimertinib Alone in Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase II Randomized Controlled Trial
Speaker: Zheng, Xiaoli, MD - The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Beijing, Beijing
12:45 PM - 12:50 PM ET

1111 - Building a Scalable Radiation Oncology Access Database: Lessons from a Geospatial Analysis of Oregon
Speaker: Butler, John, MD, PhD - University of California San Diego, San Diego, CA
12:45 PM - 12:50 PM ET

1118 - The Role of Multidimensional Individualized Clinical Management in Radiotherapy for Patients with Head and Neck Cancer: A Prospective Observational Study
Speaker: Wang, Ting - Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi
12:48 PM - 12:57 PM ET

257 - Comparison of Xerostomia in Head and Neck Cancer Patients Undergoing Radiation with and without Parotid Duct Sparing via MRI Sialography: A Randomized Control Study
Speaker: Singh, Pritanjali, MBBS, DNB - All India Institute of Medical Sciences Patna, Patna, Bihar
12:50 PM - 12:55 PM ET

1119 - Pre-Treatment Dental Findings and Clinically Significant Weight Loss during Head and Neck Radiation Therapy
Speaker: Peng, Oscar, BS - University of California, San Francisco, San Francisco, CA
12:50 PM - 1:00 PM ET

239 - Newly Adult Malignant Brainstem Glioma Treated with Anlotinib Plus Radiotherapy: A Multicenter, Phase II Study
Speaker: Chen, Biqi, MD - Sun Yat-Sen University Cancer Center, Guang Dong Province, Guangdong